Prospects for a public health perspective on psychoactive drug use

[1] [Anonymous], 1982, DARK PARADISE OPIATE

[2] Ballard P.B., 1913, BRIT J PSYCHOL MONOG, V1, P1

[3] *CDC PREV, 1999, MMWR-MORBID MORTAL W, V48, P1086

[4] Edwards G., 1994, Alcohol Policy and the Public Good

[5] GLANZ J, 1999, NY TIMES 1010, pA40

[6] Glanz J, 1999, NEW YORK TIMES 1105, pA1

[7] HIV incidence among injecting drug users in New York City syringe-exchange programmes [J]. LANCET, 1996, 348 (9033) : 987 - 991

[8] JERNIGAN D, 1997, GLOBAL IMPACT CORPOR

[9] Addiction is a brain disease, and it matters [J]. SCIENCE, 1997, 278 (5335) : 45 - 47

[10] Project DARE: No effects at 10-year follow-up [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1999, 67 (04) : 590 - 593

[1] [Anonymous], 1982, DARK PARADISE OPIATE

[2] Ballard P.B., 1913, BRIT J PSYCHOL MONOG, V1, P1

[3] *CDC PREV, 1999, MMWR-MORBID MORTAL W, V48, P1086

[4] Edwards G., 1994, Alcohol Policy and the Public Good

[5] GLANZ J, 1999, NY TIMES 1010, pA40

[6] Glanz J, 1999, NEW YORK TIMES 1105, pA1

[7] HIV incidence among injecting drug users in New York City syringe-exchange programmes [J]. LANCET, 1996, 348 (9033) : 987 - 991

[8] JERNIGAN D, 1997, GLOBAL IMPACT CORPOR

[9] Addiction is a brain disease, and it matters [J]. SCIENCE, 1997, 278 (5335) : 45 - 47

[10] Project DARE: No effects at 10-year follow-up [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1999, 67 (04) : 590 - 593